Compared with traditional in vitro diagnostic products, POCT has the three advantages of short detection time, wide detection space and easy operation, which can meet the needs of rapid and timely testing, and has become a revolutionary and rapid development segment in the IVD industry.

In 2015, the size of China's POCT market was about 8 billion yuan, and the global proportion was much lower than that of the United States and Europe, with a compound annual growth rate of more than 20%, much higher than the global average growth rate. In particular, the promotion of new medical reform, the development of emergency medicine, the improvement of epidemic disease prevention and control monitoring, and the increase of patients with chronic diseases in China in recent years have provided a huge market space for the development of POCT.

The most accurate and sensitive multi-channel fluorescence quantitative detection platform 

POCT - KOFA MA-II

MA-II Product Introduction

Microassay is a fully quantitative detection platform using fluorescence immunochromatography technology. The product covers multiple detection series such as inflammation, myocardium, diabetes, etc., and supports a variety of blood samples such as peripheral blood, whole blood, serum and plasma, and accurate test results can be obtained in 3-5 minutes.

MA-II Product Benefits:

Featured Project Recommendations

The gold standard for assessing long-term glycemic control

HbA1C

Sensitive indicators for the diagnosis and efficacy of heart failure

NT-proBNP

Preferred marker for fever screening

CRP+hs CRP

Preferred indicators for the diagnosis of bacterial infections and guidance on antibiotic use

PCT

The most desirable marker for the diagnosis of acute myocardial infarction

cTnI

Sensitive indicators for early diagnosis of acute myocardial infarction

Myo

A useful marker for early diagnosis of myocardial infarction

CK-MB